Per Frankelius, PhD, is Associate Professor at Örebro University. He is on the board of the Swedish Entrepreneurship Forum, a Fellow of the Linnean Society of London and a member of the Royal Economic Society.
His doctoral research was on the development of the first project to use DNA-technology to develop a pharmaceutical (growth hormone). His current research focuses on innovation in the arts (e.g. opera) as well as public sector innovation.
Frankelius was Secretary-General in the government inquiry (SOU) Innovative Processes 2002–03, and leader of the project (2003–05), which led to the creation of the Swedish Business School. In 2006 he was elected to membership of the Swedish Broadcasting Commission. He has been involved with several regional strategies, and is at present employed part time by Örebro Regional Council.
His research on innovation has been presented at conferences in many countries including the USA, Russia, Hungary, Finland, and the UK. As the author of some 350 publications Frankelius has been active and vocal in the national and international scientific community and society in general.